20639 ⎘
Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells; Reproductive organs Umbilical cord; Umbilical cord blood; Umbilical stem cells
Compositions of morselized umbilical cord and/or amniotic membrane and methods of use thereof
#302Compositions and methods for reprogramming adult cells through the stemness of a platelet rich fraction of blood containing platelet-like cells in humans
#303HUMAN CORD BLOOD AS A SOURCE OF NEURAL TISSUE REPAIR OF THE BRAIN AND SPINAL CORD
#304Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo
#305Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo
#306Modified blood clots
#307Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
#308TREATMENT OF RETINAL VASCULAR DISEASE USING PROGENITOR CELLS
#309Methods for treatment of premature ovarian failure and ovarian aging using regenerative cells
#310Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
#311NATURAL KILLER CELLS AND USES THEREOF
#312Isolation, cultivation and uses of stem/progenitor cells
#313METHODS FOR TREATING DEGENERATIVE DISEASES/INJURIES
#314Human tissue derived compositions and uses thereof
#315Composition including stem cell-derived microvesicles for promoting neurogenesis
#316CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF MACULAR OEDEMA AND DEGENERATION
#317NOVEL FORMULATION OF PHYSIOLOGICAL CHITOSAN-INORGANIC SALT SOLUTION/BLOOD MIXTURES FOR TISSUE REPAIR
#318Augmentation of antiinflammatory, immunomodulatory, and regenerative processes in amyotrophic lateral sclerosis using xenon and noble gas combinations
#319Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#320Compositions and methods related to hematologic recovery
#321Universal donor checkpoint inhibitor silenced/gene edited cord blood killer cells
#322Materials and methods to enhance hematopoietic stem cells engraftment procedures
#323METHOD AND SOLUTION FOR CRYOPRESERVATION OF UMBILICAL CORD BLOOD AND PERIPHERAL BLOOD
#324COMPOSITION FOR INDUCING CHONDROCYTE DIFFERENTIATION AND REGENERATING CARTILAGE TISSUE
#325Cytotherapeutics, cytotherapeutic units and methods for treatments using them
#326Methods and compositions relating to exosomes
#327Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo
#328Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
#329Devices and methods for umbilical cord processing
#330OPHTHALMIC COMPOSITIONS
#331USE OF CORD BLOOD PLASMA TO TREAT NK CELL-MEDIATED DISEASES AND IFN-γ MEDIATED DISEASES
#332METHODS OF MODULATING BONE REMODELING
#333Combination immunotherapy approach for treatment of cancer
#334Postpartum cells derived from placental tissue, and methods of making and using the same
#335Methods and systems for generation, use, and delivery of activated stem cells
#336PLACENTAL STEM CELLS DERIVED FROM POST-PARTUM MAMMALIAN PLACENTA, AND USES AND METHODS OF TREATMENT USING SAID CELLS
#337Postpartum cells derived from placental tissue, and methods of making and using the same
#338Postpartum cells derived from placental tissue, and methods of making and using the same
#339PROGENITOR CELLS FROM WHARTON'S JELLY OF HUMAN UMBILICAL CORD
#340TREATMENT OF RETINAL DEGENERATION USING PROGENITOR CELLS
#341Soft tissue repair and regeneration using postpartum-derived cells and cell products
#342HUMAN UMBILICAL CORD BLOOD-DERIVED MONOCYTES FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND DISORDERS
#343Umbilical tissue compositions and methods of use
#344Method of Treating Endometriosis
#345Compositions and methods for treating type 1 and type 2 diabetes and related disorders
#346TREATMENT OF RETINAL DEGENERATION USING PROGENITOR CELLS
#347Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo
#348TREATMENT OF INTERVERTEBRAL DISC DEGENERATION USING HUMAN UMBILICAL CORD TISSUE-DERIVED CELLS
#349Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
#350Composition for inducing direct transdifferentiation into oligodendrocyte progenitor cells from somatic cells and use thereof
#351Enhanced stem cell composition
#352Agonists that enhance binding of integrin-expressing cells to integrin receptors
#353TREATMENT OF CONDITIONS AND COMPLICATIONS IN INFANTS
#354Foetal polymix of mesenchymal stem cells under hypoxic conditions for the treatment of clinical disorders and diseases
#355Pluripotent stem cell that can be isolated from body tissue
#356METHODS OF GRADING CARCINOMAS
#357Use of cells derived from first trimester umbilical cord tissue
#358Micronized wharton's jelly
#359Composition and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
#360Method for promoting generation of stem cell-derived exosome by using thrombin
#361UMBILICAL CORD AMNIOTIC MEMBRANE PRODUCTS
#362Stem cells derived from basal portion of chorionic trophoblast layer and cell therapy comprising same
#363Method for providing an increased expression of telomerase, brain-derived neurotrophic factor, stromal cell-derived factor-1, CXC chemokine receptor 4, and/or immune regulatory factor of stem cell
#364Pharmaceutical composition for treating cerebrovascular diseases, containing stem cell-derived exosome as active ingredient
#365UMBILICAL CORD AMNIOTIC MEMBRANE PRODUCTS
#366CO-CULTURE OF PLACENTAL CELLS AND STEM CELLS FROM A SECOND SOURCE
#367METHODS OF TREATING OR PREVENTING A LUNG DISORDER
#368METHODS FOR TREATING DEGENERATIVE DISEASES/INJURIES
#369STEM CELL THERAPY FOR THE TREATMENT OF AUTISM AND OTHER DISORDERS
#370Isolation, cultivation and uses of stem/progenitor cells
#371Therapy with cells from human placenta and hematopoietic cells
#372Methods for collecting and using placenta cord blood stem cells
#373COMPOSITIONS AND METHODS FOR PROVIDING HEMATOPOIETIC FUNCTION
#374Isolation, expansion and characterization of wharton's jelly mesenchymal stem cells
#375Repair and regeneration of ocular tissue using postpartum-derived cells
#376UMBILICAL CORD AMNIOTIC MEMBRANE PRODUCTS
#377Treatment of Retinal Degeneration Using Progenitor Cells
#378Treatment of Ocular Conditions Using Progenitor Cells
#379Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo
#380COMPOSITIONS AND METHOD FOR PROMOTING NERVE GROWTH AND REGENERATION
#381Medicament for treating muscle and skeletal diseases
#382UMBILICAL CORD PRODUCTS
#383Kits and methods for processing stem cells from bone marrow or umbilical cord blood
#384METHODS OF TREATING DEGENERATIVE DISEASES/INJURIES
#385Adult and neonatal stem cell therapy to treat diabetes through the repair of the gastrointestinal tract
#386METHODS, SYSTEMS, AND COMPOSITIONS RELATING TO TREATMENT OF NEUROLOGICAL CONDITIONS, DISEASES, AND INJURIES AND COMPLICATIONS FROM DIABETES
#387Cryopreservation of umbilical cord tissue strips for cord tissue-derived stem cells
#388Use of M-CSF for preventing or treating myeloid cytopenia and related complications
#389Progenitor cells from wharton'S jelly of human umbilical cord
#390Materials and methods to enhance hematopoietic stem cells engraftment procedures
#391Isolation, cultivation and uses of stem/progenitor cells
#392Flowable matrix compositions and methods
#393Flowable matrix compositions and methods
#394Flowable matrix compositions and methods
#395MICRONIZED WHARTON'S JELLY
#396PROTECTION OF THE VASCULAR ENDOTHELIUM FROM IMMUNOLOGICALLY MEDIATED CYTOTOXIC REACTIONS WITH HUMAN CD34-NEGATIVE PROGENITOR CELLS
#397Minimal volume reprogramming of mononuclear cells
#398Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
#399Compositions and methods for treating type 1 and type 2 diabetes and related disorders
#400Agonists that enhanced binding of integrin-expressing cells to integrin receptors
#401Growth matrices for stem cell propagation in vitro and in tissue regeneration
#402Methods to rebalance the hypothalamic-pituitary-gonadal axis
#403Wound dressing nanomesh impregnated with human umbilical cord Wharton's jelly stem cells
#404Method and system for generation and use of activated stem cells
#405Compositions of morselized umbilical cord and/or amniotic membrane and methods of use thereof
#406Mesenchymal stem cell and the method of use thereof
#407CCN3 and CCN3 peptides and analogs thereof for therapeutic use
#408MICRONIZED WHARTON'S JELLY
#409INHIBITION OF RHO AND OR ROCK AND CELL TRANSPLANTATION
#410Agonists that enhanced binding of integrin-expressing cells to integrin receptors
#411Clinical grade sodium alginate for microencapsulation of myofibroblasts isolated from wharton jelly for prevention and treatment of autoimmune and inflammatory diseases
#412Medicament for treating muscle and skeletal diseases
#413Placental Stem Cells Derived From Post-Partum Mammalian Placenta, And Uses And Methods Of Treatment Using Said Cells
#414IMMUNE PRIVILEGED AND MODULATORY PROGENITOR CELLS
#415METHODS OF PREPARING PLURIPOTENT STEM CELLS
#416Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
#417LITHIUM STIMULATION OF CORD BLOOD STEM CELL PROLIFERATION AND GROWTH FACTOR PRODUCTION
#418Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
#419Native wharton's jelly stem cells and their purification
#420Placental Stem Cells Derived From Post-Partum Mammalian Placenta, And Uses And Methods Of Treatment Using Said Cells
#421Compositions and methods for reducing frequency and/or severity of headache
#422STEM CELL IDENTIFICATION AND PURIFICATION METHOD
#423Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy
#424Devices and methods for selecting apoptosis-signaling resistant cells, and uses thereof
#425MicroRNAs for the generation of astrocytes
#426Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy
#427Pharmaceutical Kits Comprising Mesenchymal Stem Cells
#428ORGANOIDS COMPRISING DECELLULARIZED AND REPOPULATED PLACENTAL VASCULAR SCAFFOLD
#429Materials and methods to enhance hematopoietic stem cells engraftment procedures
#430Ischemic tissue cell therapy
#431Enhanced stem cell composition
#432Methods for improved wound closure employing olivamine and endothelial cells
#433Self-assembled composite ultrasmall peptide-polymer hydrogels
#434Activated T Cells
#435USE OF HUMAN CORD BLOOD-DERIVED PLURIPOTENT CELLS FOR THE TREATMENT OF DISEASE
#436Use Of Umbilical Cord Blood To Treat Individuals Having A Disease, Disorder Or Condition
#437Kits and methods for processing stem cells from bone marrow or umbilical cord blood
#438hUTC as therapy for Alzheimer's disease
#439HIV-RESISTANT STEM CELLS AND USES THEREOF
#440CARTILAGE CELL TREATMENT COMPRISING COLLAGEN, HYALURONIC ACID DERIVATIVE, AND STEM CELL DERIVED FROM MAMMAL UMBILICAL CORD
#441MATERIALS AND METHODS FOR CONTROLLING VASCULOGENESIS FROM ENDOTHELIAL COLONY FORMING CELLS
#442Regeneration and repair of neural tissue using postpartum-derived cells
#443Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
#444Composition and method to improve the therapeutic effect of stem cells
#445Methods of modulating bone remodeling
#446METHODS AND COMPOSITIONS FOR LONG TERM HEMATOPOIETIC REPOPULATION
#447Compositions for the in vitro derivation and culture of embryonic stem (ES) cell lines with germline transmission capability and for the culture of adult stem cells
#448Production of dentin, cementum and enamel by cells
#449Repair of Neurodegenerative Diseases
#450Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#451Method to assess patterns of molecular expression
#452Administering umbilical cord blood-derived mesenchymal stem cells to treat nerve injury
#453hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS
#454Flowable matrix compositions and methods
#455Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells
#456TREATMENT OF PREMATURE BIRTH COMPLICATIONS
#457Progenitor cells from Wharton's jelly of human umbilical cord
#458Uses of IL-12 and the IL-12 receptor positive cell in tissue repair and regeneration
#459Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof
#460PHARMACEUTICAL COMPOSITION FOR TREATING SKIN WOUND
#461Agonists that enhance binding of integrin-expressing cells to integrin receptors
#462Compositions and methods for CXCR4 signaling and umbilical cord blood stem cell engraftment
#463Methods and compositions for the clinical derivation of an allogenic cell and therapeutic uses
#464CCN3 and CCN3 peptides and analogs thereof for therapeutic uses
#465Native wharton's jelly stem cells and their purification
#466Methods of improving central nervous system functioning
#467COMPOSITIONS AND METHODS FOR PROVIDING HEMATOPOIETIC FUNCTION
#468COMPOSITIONS AND METHODS FOR PROVIDING HEMATOPOIETIC FUNCTION WITHOUT HLA MATCHING
#469UMBILICAL CORD STEM CELL SECRETED PRODUCT DERIVED TOPICAL COMPOSITIONS AND METHODS OF USE THEREOF
#470MULTIPOTENT ADULT STEM CELL DERIVED FROM CANINE UMBILICAL CORD BLOOD, PLACENTA AND CANINE FETUS HEART, METHOD FOR PREPARING THE SAME AND CELLULAR THERAPEUTICS CONTAINING THE SAME
#471Cellular Compositions and Methods of Making and Using Them
#472Compositions and methods for enhancing bioenergetic status in female germ cells
#473Proangiogenic compositions, method for preparing same, and uses thereof
#474PHARMACEUTICAL KITS COMPRISING MESENCHYMAL STEM CELLS
#475Regeneration and repair of neural tissue using postpartum-derived cells
#476Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy
#477NOVEL FORMULATION OF PHYSIOLOGICAL CHITOSAN-INORGANIC SALT SOLUTION/BLOOD MIXTURES FOR TISSUE REPAIR
#478Method for reducing heat loss in neonatal mammalian subjects by transplanting brown adipocytes or precursors thereof
#479Postpartum cells derived from umbilical tissue and methods of making and using the same
#480Therapeutic Conditioned Media
#481PRODUCTIONS OF ARTIFICIAL TISSUES BY MEANS OF TISSUE ENGINEERING USING AGAROSE-FIBRIN BIOMATERIALS
#482ALLOGENEIC STEM CELL TRANSPLANTS IN NON-CONDITIONED RECIPIENTS
#483SSEA3(+) pluripotent stem cell that can be isolated from body tissue
#484MESENCHYMAL STEM CELL AND THE METHOD OF USE THEREOF
#485MESENCHYMAL STEM CELL AND THE METHOD OF USE THEREOF
#486Mesenchymal stem cell and a method of use thereof
#487MESENCHYMAL STEM CELL AND THE METHOD OF USE THEREOF
#488PHARMACEUTICAL KITS COMPRISING MESENCHYMAL STEM CELLS
#489Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
#490TREATMENT OF ACNE BY CONDITIONED MEDIA
#491METHOD FOR TREATING PANCREATITIS WITH MESENCHYMAL STEM CELLS
#492Methods for complex tissue engineering
#493UMBILICAL CORD AMNIOTIC MEMBRANE PRODUCTS
#494Method for differentiation of stem cells into vascular cells and the induction of angiogenesis using the same
#495METHODS AND COMPOSITIONS FOR LONG TERM HEMATOPOIETIC REPOPULATION
#496THERAPEUTIC VESICLES
#497Reversal of Adult Onset Disorders with Granulocyte-Colony Stimulating Factors
#498COMPOSITION FOR TREATING BALDNESS WITH STEM CELL DERIVED FROM UMBILICAL CORD BLOOD
#499HIV-RESISTANT STEM CELLS AND USES THEREOF
#500PLACENTAL STEM CELLS DERIVE FROM POST-PARTUM MANMALIAN PLACENTA, AND USES AND METHODS OF TREATMENT USING SAID CELLS
#501Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
#502Materials and methods to enhance hematopoietic stem cells engraftment procedures
#503Method for controlling proliferation of cord blood hematopoietic stem cells and use thereof
#504TREATMENT OF INTERVERTEBRAL DISC DEGENERATION USING HUMAN UMBILICAL CORD TISSUE-DERIVED CELLS
#505Ischemic tissue cell therapy
#506Treatment of brain damage using umbilical cord blood cells
#507ADULT BONE MARROW CELL TRANSPLANTATION TO TESTES CREATION OF TRANSDIFFERENTIATED TESTES GERM CELLS, LEYDIG CELLS AND SERTOLI CELLS
#508MESENCHYMAL STEM CELL AND THE METHOD OF USE THEREOF
#509Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
#510METHODS AND COMPOSITIONS RELATING TO STEM CELL TRANSPLANTATION
#511USE OF CELLS TO FACILITATE TARGETED DELIVERY OF NANOPARTICLE THERAPIES
#512Activated T Cells
#513THERAPEUTIC PREPARATIONS CONTAINING WHARTON'S JELLY
#514Methods of improving central nervous system functioning
#515MAPC TREATMENT OF BRAIN INJURIES AND DISEASES
#516Repair and regeneration of ocular tissue using postpartum-derived cells
#517Method for expansion of stem cells
#518Regeneration and repair of neural tissue using postpartum-derived cells
#519hUTC as therapy for Alzheimer's disease
#520Intrathecal administration of autologous stem cells to treat intraventricular hemorrhage in premature infants
#521Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#522Lithium stimulation of cord blood stem cell proliferation and growth factor production
#523Conditioned media and methods of making a conditioned media
#524Treatment of lung and pulmonary diseases and disorders
#525UMBILICAL CORD STEM CELL SECRETED PRODUCT DERIVED TOPICAL COMPOSITIONS AND METHODS OF USE THEREOF
#526METHODS FOR USING ALDHbr CELLS TO SUPPLEMENT STEM CELL TRANSPLANTATION
#527CELLULAR COMPOSITIONS AND METHODS OF MAKING AND USING THEM
#528Vascularized islets and methods of producing same
#529Neural cell proliferation induced through the culture of neural cells with umbilical cord blood-derived mesenchymal stem cells
#530Methods of organ regeneration using Hox11-expressing pluripotent cells
#531STEM CELL TARGETING METHODS
#532MULTIPOTENT ADULT STEM CELL DERIVED FROM CANINE UMBILICAL CORD BLOOD, PLACENTA AND CANINE FETUS HEART, METHOD FOR PREPARING THE SAME AND CELLULAR THERAPEUTICS CONTAINING THE SAME
#533Treatment of disc degenerative disease
#534MAPC therapeutics without adjunctive immunosuppressive treatment
#535Methods for Treating Degenerative Diseases/Injuries
#536Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo
#537Treatment of erectile dysfunction by stem cell therapy
#538Immune privileged and modulatory progenitor cells
#539Progenitor cells from wharton's jelly of human umbilical cord
#540HUMAN CORD BLOOD DERIVED UNRESTRICTED SOMATIC STEM CELLS (USSC)
#541METHODS AND COMPOSITIONS FOR TREATING BASEMENT MEMBRANE DISORDERS
#542Treatment of ischemia using stem cells
#543HUMAN HEMATOPOIETIC MULTIPOTENT PROGENITOR CELLS
#544Use of human cord blood-derived pluripotent cells for the treatment of disease
#545Method of reducing blood glucose levels in type 2 diabetes patients by administering granulocyte-colony stimulating factor
#546TREATMENT OF PREMATURE BIRTH COMPLICATIONS
#547Methods for collecting and using placenta cord blood stem cell
#548Cell/ligand marking system, wherein the marker is of Eph type, cell material comprising said system, method for preparing same and proangiogenetic use
#549Compositions for the in vitro derivation and culture of embryonic stem (ES) cell lines with germline transmission capability and for the culture of adult stem cells
#550TREATMENT OF MUSCULAR DYSTROPHY WITH CORD BLOOD CELLS
#551CELL COMPOSITION FOR TISSUE REGENERATION
#552Composition For Treatment of Articular Cartilage Damage
#553Composition For Treatment Of Articular Cartilage Damage
#554Composition and Method for Inhibition of Melanin Synthesis
#555Composition For Treatment Of Articular Cartilage Damage
#556Embryonic cell compositions for wound treatment
#557Method of treating lung diseases using cells separated or proliferated from umbilical cord blood
#558Treatment of spinal injuries using human umbilical mesenchymal stem cells
#559Umbilical Cord Stem Cell Composition & Method of Treating Neurological Diseases
#560Method of Stem Cell Therapy for Cardiovascular Repair
#561Stem Cell Therapy for the Treatment of Autism and Other Disorders
#562Cell fractions containing cells capable of differentiating into neural cells
#563Cell-based therapies for treating liver disease
#564Method for the Treatment of Myelodysplastic Syndromes Using 1-Oxo-2-(2,6-Dioxopiperidin-3-Yl-)-4-Methylisoindoline
#565Co-culture of placental stem cells and stem cells from a second source
#566Plasma-depleted, not erythrocyte-depleted, cord blood compositions and method of making
#567Placental stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
#568Method of treating a hematopoietic associated disease or disorder with plasma-depleted, but not erythrocyte-depleted cord blood compositions
#569Co-culture of placental stem cells and stem cells from a second source
#570Soft tissue repair and regeneration using stem cell products
#571Co-culture of placental stem cells and stem cells from a second source
#572ADULT BONE MARROW CELL TRANSPLANTATION TO TESTES CREATION OF TRANSDIFFERENTIATED TESTES GERM CELLS, LEYDIG CELLS AND SERTOLI CELLS
#573Human umbilical cord tissue cells for inhibiting adverse immune response in histocompatibility-mismatched transplantation
#574Methods and compositions for administering stem cells
#575Methods and compositions for regenerating tissue
#576Methods and compositions for directing stem cells to the liver
#577Methods and compositions for directing stem cells to the heart
#578Methods and compositions for enhancing engraftment of hematopoietic stem cells
#579Human cord blood as a source of neural tissue repair of the brain and spinal cord
#580Methods and compositions for mobilizing stem cells
#581Composition Comprising Separated or Proliferated Cells from Umbilical Cord Blood for Treating Developmental and/or Chronic Lung Disease
#582Use of umbilical cord blood stem cells to treat ischemic event
#583Hox11+, CD45− cells and methods of organ regeneration using the same
#584Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
#585Cytotherapeutics, cytotherapeutic units and methods for treatments using them
#586Use of umbilical cord blood to treat individuals having a disease, disorder or condition
#587Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#588Reversal of Adult Onset Disorders with Granulocyte-Colony Stimulating Factors
#589Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#590Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#591PLASMA-DEPLETED, NON-RED BLOOD CELL-DEPLETED CORD BLOOD COMPOSITIONS AND METHODS OF USE
#592Repair and regeneration of ocular tissue using postpartum-derived cells
#593Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#594Method of providing readily available cellular material derived from cord blood, and a composition thereof
#595Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
#596Method for expansion of stem cells
#597Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
#598Novel methods, compositions and devices for inducing neovascularization
#599Method of potentiating inflammatory and immune modulation for cell and drug therapy
#600Cartilage and bone repair and regeneration using postpartum-derived cells